UNSPSC 51142546: Bromocriptine mesilate or mesylate

This classification denotes a neuroprotective agent with the molecular formula C32H40BrN5O5.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FFP983J3OD, chemically known as 2-bromo-alpha-ergocryptine, methanesulfonate but more generally known as bromocriptine mesilate, which bears US NIH Compound Identifier 31100. European Medicines Agency schedules Bromocriptine mesilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00878MIG.

UNSPSC 51142546 Bromocriptine mesilate or mesylate is a Commodity code that shows minimal alignment with recent state and local procurement activity. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and drug deactivation systems for community health initiatives, which falls outside the pharmaceutical scope of the code's nominal classification. The mismatch suggests either a coding error in the opportunity posting or a tagging anomaly in the source system rather than genuine demand for bromocriptine mesilate at the state or local level.

No other recent solicitations appear in the available record for this Commodity code. Without additional opportunities grounding the scope of work, issuing-body patterns, or geographic concentration, a meaningful market assessment cannot be formed. Firms evaluating this code should verify whether state and local procurement offices are actually buying bromocriptine mesilate as a therapeutic agent or whether activity under this code reflects broader pharmaceutical purchasing that has been misclassified. The single naloxone procurement does not support a business development strategy focused on this Commodity.